Reserveage

Resveratrol Gummies Grape Flavored

D
N+ Score64
Longevity & NAD+Serving: 2 Gummy(ies)Type: Other Combinations

This Resveratrol Gummy product, categorized under Longevity & NAD+, received an N+ Score of 64, earning a 'D' grade, indicating an average tier product. It contains a total of 5 ingredients, with full label transparency. Notably, the product provides Vitamin C at 150mg, which is considered a clinical dose. However, the primary ingredient, Trans-Resveratrol at 100mg, is generally below dosages used in most human clinical studies for longevity support. This product may appeal to individuals seeking a convenient, grape-flavored gummy format for general antioxidant support, but those looking for robust resveratrol dosages for specific longevity benefits might consider alternatives.

About This Product

Resveratrol Gummies Grape Flavored by Reserveage is a longevity & nad+ supplement containing 5 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

Notable clinical-dose ingredients include Vitamin C.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Calories20.000 Calorie(s)N/A
Vitamin C150.000 mgAdequate
Total Carbohydrates5.000 Gram(s)N/A
Sodium5.000 mgN/A
trans-Resveratrol100.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.